The new, clearer design is intended to allow readers to customise http://www.in-Pharm...
You must be logged in to view the whole article.
Click here if you require signing up
BD's board announces dividend to holders of record on 7 June 2013
Empire Genomics secures licence to DNA biomarker for neuroendocrine prostate cancer test
Mayo Clinic, Cancer Genetics set up diagnostic tests JV
H Lundbeck reports promising pre-clinical animal model data of antidepressant vortioxetine
CytRx reports promising Phase Ib data for aldoxorubicin in solid tumours
Roche to introduce automated lab solution in autumn 2013
Labtest Diagnostica to distribute Chembio's products in Brazil
Sanofi, Regeneron unveil promising Phase IIa data for dupilumab in asthma
Cancer Genetics to provide oncology tests, services to MultiPlan network
EMA validates Gilead's application for hepatitis C treatment sofosbuvir
Roche's Avastin fails to secure NICE nod for advanced ovarian cancer
Ceregene unveils more Phase IIb data for Parkinson's disease gene therapy CERE-120
Sunovion unveils encouraging data from two studies of Latuda for bipolar depression